Accord Healthcare is a global pharmaceutical company based in Durham, North Carolina, specializing in the development, manufacturing, and distribution of affordable generic, biosimilar, and specialty medicines. Founded in 2002, Accord operates in over 85 countries and is recognized as one of the fastest-growing companies in the generic pharmaceutical sector, with a portfolio of more than 4,000 product approvals. The company offers a wide range of services, including pharmaceutical development, state-of-the-art manufacturing, global distribution, regulatory support, and active launch programs for new products. Accord's product portfolio spans various therapeutic areas such as oncology, cardiology, urology, respiratory, neurology, psychiatry, diabetes, anti-infectives, and critical care. They produce multiple dosage forms, including oral solids, injectables, and topicals, ensuring high-quality output for both hospital and retail pharmacies. Accord Healthcare is committed to improving patient access to essential medicines worldwide.